Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SCLXthis companyScilex Holding Company	$1.67	-0.33×	-0.65×	4.45×	-0.73×	-2815.4%	49.7%	-900.1%	-1185.8%	172.7%	1031.6%	2.7%	-0.64×	-0.36×	-23.76×	0.08×	0.0%	2	-12.87	2	C
ABOSAcumen Pharmaceuticals, Inc.	$0.24	-1.06×	1.81×	0×	-0.9×	56.7%	0.0%	0.0%	0.0%	-172.3%	-121.7%	-90.5%	0.44×	0.19×	-29.32×	4.07×	0.0%	2	-11.67	2	C
AGENAgenus Inc.	$7.55	-923.53×	-0.34×	0.82×	6.84×	-468.1%	29.6%	-18.0%	0.1%	-0.0%	-34.5%	-170.2%	-1.24×	5.34×	-0.37×	0.41×	0.0%	6	-14.32	2	C+
ALECAlector, Inc.	$2.40	-1.12×	5.24×	7.63×	-0.99×	-108.0%	54.1%	-692.8%	-679.2%	-466.3%	-62.5%	-114.6%	1.18×	0.22×	0×	3.83×	0.0%	2	-7.33	2	C
CTORCitius Oncology, Inc.	$0.57	-5.97×	3.32×	0×	-6.33×	-82.3%	0.0%	0.0%	0.0%	-55.2%	-45.7%	-3.7%	0.08×	0.01×	-107.89×	0.56×	0.0%	3	-2.3	2	C
INOInovio Pharmaceuticals, Inc.	$1.51	-0.96×	3.39×	1,248.52×	-0.57×	-63.4%	100.0%	-132871.3%	-130000.0%	-352.5%	-259.4%	-109.0%	0.39×	0.43×	0×	1.4×	0.0%	0	-54.95	1	C-
Peer median	—	-1.12×	3.32×	0.82×	-0.9×	-82.3%	29.6%	-18.0%	0.0%	-172.3%	-62.5%	-109.0%	0.39×	0.22×	-0.37×	1.4×	0.0%	2	-11.67	2	—